{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:28:29Z","timestamp":1738387709744,"version":"3.35.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fujian Province Science and Technology Innovation Joint Fund Project","award":["2023Y9323"],"award-info":[{"award-number":["2023Y9323"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"abstract":"<jats:p>Previous investigations through observation have found that matrix metalloproteinase-3 (MMP-3) has benefits for ankylosing spondylitis (AS) but it is uncertain whether there is a true positive causal connection. Our goal was to demonstrate the relationship between AS and MMP-3. We executed Mendelian randomization (MR) research utilizing genome-wide association studies genetic data (n\u2005=\u200521,758) for MMP-3 publicly available from IEU Open and genome-wide association studies data for AS (n\u2005=\u2005297,932) from FinnGen Biobank. The specific MR protocols were weighted median, weighted mode, MR-Egger, and inverse-variance weighted (IVW). Subsequently, the Cochran <jats:italic toggle=\"yes\">Q<\/jats:italic> evaluate, MR pleiotropy residual sum and outlier, and MR-Egger intercept were used to evaluate the heterogeneity and multiplicative effects of instrumental variables. The IVW method demonstrated that MMP-3 had a causal effect on AS (odds ratio, 0.9047 [95% confidence interval, 0.8080\u20131.0129]; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0823). Certainly, other MR techniques were in accordance with the tendency of the IVW method (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .05), and sensitivity testing verified the reliability of this MR result. This MR study substantiates the causal role of MMP-3 in the development of AS, offering valuable insights into the disease mechanism and potential therapeutic targets.<\/jats:p>","DOI":"10.1097\/md.0000000000041373","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:00:23Z","timestamp":1738353623000},"page":"e41373","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The causal effect of matrix metalloproteinase-3 on ankylosing spondylitis: Evidence from Mendelian randomization"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1554-1524","authenticated-orcid":false,"given":"Wenkai","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Emergency, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China"},{"name":"Department of Emergency, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Emergency, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China"},{"name":"Department of Emergency, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfa","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China"},{"name":"Department of Emergency, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wubing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Emergency, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China"},{"name":"Department of Emergency, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJM197003122821107","article-title":"Ankylosing spondylitis.","volume":"282","author":"Calabro","year":"1970","journal-title":"N Engl J Med"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/key128","article-title":"Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis.","volume":"58","author":"van der Heijde","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"17068","DOI":"10.4238\/2015.December.16.7","article-title":"Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis.","volume":"14","author":"Gao","year":"2015","journal-title":"Genet Mol Res"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00296-011-1852-8","article-title":"Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.","volume":"32","author":"Soliman","year":"2012","journal-title":"Rheumatol Int"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"eadf6537","DOI":"10.1126\/sciadv.adf6537","article-title":"Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma.","volume":"9","author":"O\u2019Callaghan","year":"2023","journal-title":"Sci Adv"},{"key":"R6-20250131","first-page":"814350","article-title":"Circulating levels of soluble receptor activator of NF-\u03baB ligand and matrix metalloproteinase 3 (and their antagonists) in Asian Indian patients with ankylosing spondylitis.","volume":"2013","author":"Dhir","year":"2013","journal-title":"Int J Rheumatol"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1136\/ard.2008.099481","article-title":"Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.","volume":"68","author":"Wei","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R8-20250131","first-page":"a041302","article-title":"Mendelian randomization.","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R9-20250131","first-page":"100848","article-title":"Association between uric acid and risk of venous thromboembolism in East Asian populations: a cohort and Mendelian randomization study.","volume":"39","author":"Weng","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"R10-20250131","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","article-title":"Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.","volume":"2","author":"Folkersen","year":"2020","journal-title":"Nat Metab"},{"key":"R11-20250131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40120-021-00310-y","article-title":"Migraine and ischemic stroke: a Mendelian randomization study.","volume":"11","author":"Shu","year":"2022","journal-title":"Neurol Ther"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2023.05.008","article-title":"Insights into modifiable risk factors of erectile dysfunction, a wide-angled Mendelian randomization study.","volume":"58","author":"Xiong","year":"2024","journal-title":"J Adv Res"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13075-020-02202-2","article-title":"Sex hormone-binding globulin and arthritis: a Mendelian randomization study.","volume":"22","author":"Qu","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R14-20250131","doi-asserted-by":"crossref","first-page":"1175421","DOI":"10.3389\/fimmu.2023.1175421","article-title":"Circulating levels of cytokines and risk of cardiovascular disease: a Mendelian randomization study.","volume":"14","author":"Wei","year":"2023","journal-title":"Front Immunol"},{"key":"R15-20250131","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.bor.0000231904.04548.09","article-title":"Matrix metalloproteinase expression in the spondyloarthropathies.","volume":"18","author":"Zhu","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"e00752","DOI":"10.1002\/mgg3.752","article-title":"Association study between matrix metalloproteinase-3 gene (MMP3) polymorphisms and ankylosing spondylitis susceptibility.","volume":"7","author":"Zhu","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"R17-20250131","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/art.22589","article-title":"Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.","volume":"56","author":"Maksymowych","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10067-010-1528-x","article-title":"Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNF\u03b1 inhibitors.","volume":"29","author":"Pedersen","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"838809","DOI":"10.3389\/fgene.2022.838809","article-title":"Evaluating the causal effects of TIMP-3 on ischaemic stroke and intracerebral haemorrhage: a Mendelian randomization study.","volume":"13","author":"Xiao","year":"2022","journal-title":"Front Genet"},{"key":"R20-20250131","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3899\/jrheum.101128","article-title":"Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis.","volume":"38","author":"Arends","year":"2011","journal-title":"J Rheumatol"},{"key":"R21-20250131","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R22-20250131","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1186\/s12885-021-09067-x","article-title":"Blood pressure and risk of cancer: a Mendelian randomization study.","volume":"21","author":"Chan","year":"2021","journal-title":"BMC Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:00:33Z","timestamp":1738353633000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041373","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}